|
1.
|
|
Association of extracellular matrix metalloproteinase inducer in endometrial carcinoma with patient outcomes and clinicopathologenesis using monoclonal antibody 12C3. 2007/01
|
|
2.
|
|
Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer. 2007/01
|
|
3.
|
|
Irinotecan hydrochloride (CPT-11) and cisplatin as first-line chemotherapy after surgery for ovarian clear cell adenocarcinoma. 2007/01
|
|
4.
|
|
AOCS Study Group..Integrated Copy Number and Expression Analysis of Chemoresistan Ovarian Carcinomas. 2009/02
|
|
5.
|
|
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. 2009/02
|
|
6.
|
|
Establishment of an immortalized human extravillous trophoblast cell line by retroviral infection of E6/E7/hTERT and its transcriptional profile during hypoxia and reoxygenation. 2009/03
|
|
7.
|
|
Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts． 2009/05
|
|
8.
|
|
Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts． 2009/05
|
|
9.
|
|
Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. 2009/12
|
|
10.
|
|
Is the resistance of gemcitabine for pancreatic cancer settled only by overexpression of deoxycitidine kinase? 2010/02
|
|
11.
|
|
Is the resistance of gemcitabine for pancreatic cancer settled only by overexpression of deoxycytidine kinase? 2010/02
|
|
12.
|
|
The landscape of somatic copy number alteration across human cancer types. 2010/02
|
|
13.
|
|
Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and follapian tubal cancer. 2010/07
|
|
14.
|
|
Molecular genetic of gynecological cancer. 2010/08
|
|
15.
|
|
Australian Ovarian Cancer Study.Copy number analysis identifies novel interactions between genomic loci in ovarian cancer. 2010/09
|
|
16.
|
|
Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010. 2011/01
|
|
17.
|
|
Cyclin D1 predicts the prognosis of advanced serous ovarian cancer. 2011/01
|
|
18.
|
|
IL6-STAT3-HIF signalling and therapeutic response to the angiogenesis inhibitor, sunitinib, in ovarian clear cell cancer. 2011/04
|
|
19.
|
|
Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer. 2011/05
|
|
20.
|
|
Amyloid {beta} Enhances Migration of Endothelial Progenitor Cells by Upregulating CX3CR1 in Response to Fractalkine, Which May Be Associated with Development of Choroidal Neovascularization. 2011/07
|
|
21.
|
|
High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway. 2012/03/01
|
|
22.
|
|
Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinoma. 2012/03/19
|
|
23.
|
|
Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest. 2012/04
|
|
24.
|
|
Current movement in global clinical trials--discussion at Gynecologic Cancer Intergroup (GCIG). 2012/06
|
|
25.
|
|
Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinoma. 2012/06
|
|
26.
|
|
Molecular genetic of ovarian cancer. 2012/06
|
|
27.
|
|
A pilot study of CD147 protein expression in epithelial ovarian cancer using monoclonal antibody 12C3. 2012/09
|
|
28.
|
|
Cytokine gene expression signature in ovarian clear cell carcinoma. 2012/09
|
|
29.
|
|
Cytokine gene expression signature in ovarian clear cell carcinoma. 2012/09
|
|
30.
|
|
Pilot study of CD147 protein expression in epithelial ovarian cancer using monoclonal antibody 12C3. 2012/09
|
|
31.
|
|
Pilot study of CD147 protein expression in epithelial ovarian cancer using monoclonal antibody 12C3. 2012/09
|
|
32.
|
|
Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line chemotherapy. 2012/12
|
|
33.
|
|
The cancer stem cell marker CD133 interacts with plakoglobin and controls desmoglein-2 protein levels. 2013/01
|
|
34.
|
|
ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma. 2013/02
|
|
35.
|
|
Novel gene therapy viral vector using non-oncogenic lymphotropic herpesvirus 2013/02
|
|
36.
|
|
Novel gene therapy viral vector using non-oncogenic lymphotropic herpesvirus 2013/02/11
|
|
37.
|
|
Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia. 2013/03
|
|
38.
|
|
Clinical experience of J-VAC drain for skin closure in the laparotomy of obstetrics and gynecology. 2014/04
|
|
39.
|
|
Impact of Surgical Staging in Stage I Clear Cell Adenocarcinoma of the Ovary. 2014/09
|
|
40.
|
|
Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary. 2014/09/24
|
|
41.
|
|
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary. 2014/11
|
|
42.
|
|
MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma. 2014/11
|
|
43.
|
|
MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma 2014/11/03
|
|
44.
|
|
DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma. 2015/02
|
|
45.
|
|
Somatic copy number alterations associated with Japanese or endometriosis in ovarian clear cell adenocarcinoma. 2015/02
|
|
46.
|
|
Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer. 2015/03
|
|
47.
|
|
Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing. 2015/04/03
|
|
48.
|
|
Increased expression of perforin, granzyme B, and C5b-9 in villitis of unknown etiology 2015/05/31
|
|
49.
|
|
Novel Nonsense Mutation in the NLRP7 Gene Associated with Recurrent Hydatidiform Mole. 2015/11/26
|
|
50.
|
|
FISH analysis and chromosomal SNP microarray analysis of a fetus with supernumerary marker chromosome detected through amniocentesis 2016/03
|
|
51.
|
|
Prenatal imaging and pathology of placental mesenchymal dysplasia: a report of three cases 2016/03
|
|
52.
|
|
Laparoscopic conservative surgery for massive ovarian edema with torsion 2016/05
|
|
53.
|
|
Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma. 2016/07/11
|
|
54.
|
|
Feasibility of reduced port surgery applying Higuchi's transverse incision 2017/02
|
|
55.
|
|
Cancer translational research and cancer registry studies JGOG's activities 2017/04
|
|
56.
|
|
Prognostic impact of interleukin-6 expression in stage I ovarian clear cell carcinoma. 2017/09
|
|
57.
|
|
Gene aberration profile of tumors of adolescent and young adult females. 2017/12/29
|
|
58.
|
|
Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer. 2018/02
|
|
59.
|
|
Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers. 2019/01/24
|
|
60.
|
|
Management and new strategy of ovarian clear cell carcinoma. 2020/03
|
|
61.
|
|
Neoadjuvant Chemotherapy for Patients With Diaphragmatic Lesions: A Prognostic Postoperative Analysis. 2020/05
|
|
Display 5 items
|
|
Display all(61)
|
